Thiago Alves da Costa

Thiago Alves da Costa

Auto-generated profile, based on publicly available information

Thiago Alves da Costa

Department of Structural and Functional Biology, Institute of Biology, University of Campinas (Unicamp), Campinas, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RTRodolfo Thome
Rodolfo Thome
AMAdriel S. Moraes
Adriel S. Moraes
ABAndré Luis Bombeiro
André Luis Bombeiro
AFAlessandro dos Santos Farias
Alessandro dos Santos Farias
CRCarolina Francelin Rovarotto
Carolina Francelin Rovarotto
LVLIANA VERINAUD
LIANA VERINAUD
The modulation of inflammatory processes is a necessary step, mostly orchestrated by regulatory T (Treg) cells and suppressive Dendritic Cells (DCs), to prevent the development of deleterious responses and autoimmune diseases. Therapies that focused on adoptive transfer of Treg cells or their expansion in vivo achieved great success in controlling inflammation in several experimental models. Chloroquine (CQ), an anti-malarial drug, was shown to reduce inflammation, although the mechanisms are still obscure. In this context, we aimed to access whether chloroquine treatment alters the frequency of Treg cells and DCs in normal mice. In addition, the effects of the prophylactic and therapeutic treatment with CQ on Experimental Autoimmune Encephalomyelitis (EAE), an experimental model for human Multiple Sclerosis, was investigated as well. EAE was induced in C57BL/6 mice by immunization with myelin oligodendrocyte glycoprotein (MOG35–55) peptide. C57BL/6 mice were intraperitoneally treated with chloroquine. Results show that the CQ treatment provoked an increase in Treg cells frequency as well as a decrease in DCs. We next evaluated whether prophylactic CQ administration is capable of reducing the clinical and histopathological signs of EAE. Our results demonstrated that CQ-treated mice developed mild EAE compared to controls that was associated with lower infiltration of inflammatory cells in the central nervous system CNS) and increased frequency of Treg cells. Also, proliferation of MOG35–55-reactive T cells was significantly inhibited by chloroquine treatment. Similar results were observed when chloroquine was administrated after disease onset. We show for the first time that CQ treatment promotes the expansion of Treg cells, corroborating previous reports indicating that chloroquine has immunomodulatory properties. Our results also show that CQ treatment suppress the inflammation in the CNS of EAE-inflicted mice, both in prophylactic and therapeutic approaches. We hypothesized that the increased number of regulatory T cells induced by the CQ treatment is involved in the reduction of the clinical signs of EAE.

12 November 2013 in Immunology & Cell Biology
Verified
Journal Article
Closed access
RTRodolfo Thome
Rodolfo Thome
LILuidy Kazuo Issayama
Luidy Kazuo Issayama
RDRosaria DiGangi
Rosaria DiGangi
ABAndre Luis Bombeiro
Andre Luis Bombeiro
TCThiago Alves da Costa
Thiago Alves da Costa
LVLiana Verinaud
Liana Verinaud

4 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LVLiana Verinaud
Liana Verinaud
SLStefanie COSTA PINTO Lopes
Stefanie COSTA PINTO Lopes
IPIsabel Cristina Naranjo Prado
Isabel Cristina Naranjo Prado
FZFábio Zanucoli
Fábio Zanucoli
TCThiago Alves da Costa
Thiago Alves da Costa
RTRodolfo Thome
Rodolfo Thome
Inflammation is a necessary process to control infection. However, exacerbated inflammation, acute or chronic, promotes deleterious effects in the organism. Violacein (viola), a quorum sensing metabolite from the Gram-negative bacterium Chromobacterium violaceum, has been shown to protect mice from malaria and to have beneficial effects on tumors. However, it is not known whether this drug possesses anti-inflammatory activity. In this study, we investigated whether viola administration is able to reduce acute and chronic autoimmune inflammation. For that purpose, C57BL/6 mice were intraperitoneally injected with 1 μg of LPS and were treated with viola (3.5mg/kg) via i.p. at the same time-point. Three hours later, the levels of inflammatory cytokines in the sera and phenotypical characterization of leukocytes were determined. Mice treated with viola presented a significant reduction in the production of inflammatory cytokines compared with untreated mice. Interestingly, although viola is a compound derived from bacteria, it did not induce inflammation upon administration to naïve mice. To test whether viola would protect mice from an autoimmune inflammation, Experimental Autoimmune Encephalomyelitis (EAE)-inflicted mice were given viola i.p. at disease onset, at the 10th day from immunization. Viola-treated mice developed mild EAE disease in contrast with placebo-treated mice. The frequencies of dendritic cells and macrophages were unaltered in EAE mice treated with viola. However, the sole administration of viola augmented the levels of splenic regulatory T cells (CD4+Foxp3+). We also found that adoptive transfer of viola-elicited regulatory T cells significantly reduced EAE. Our study shows, for the first time, that violacein is able to modulate acute and chronic inflammation. Amelioration relied in suppression of cytokine production (in acute inflammation) and stimulation of regulatory T cells (in chronic inflammation). New studies must be conducted in order to assess the possible use of viola in therapeutic approaches in human autoimmune diseases.

11 May 2016 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
RTRodolfo Thome
Rodolfo Thome
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
TCThiago Alves da Costa
Thiago Alves da Costa
LILarissa Ishikawa
Larissa Ishikawa
Thais Fernanda de Campos Fraga-SilvaThais Fernanda de Campos Fraga-Silva
Thais Fernanda de Campos Fraga-Silva
LVLIANA VERINAUD
LIANA VERINAUD

13 October 2014 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
LVLiana Verinaud
Liana Verinaud
LILuidy Kazuo Issayama
Luidy Kazuo Issayama
FZFábio Zanucoli
Fábio Zanucoli
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
TCThiago Alves da Costa
Thiago Alves da Costa
RTRodolfo Thome
Rodolfo Thome

16 February 2016 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MFMarina Barreto Felisbino
Marina Barreto Felisbino
TCThiago Alves da Costa
Thiago Alves da Costa
MGMaria Silvia Viccari Gatti
Maria Silvia Viccari Gatti
MMMaria Luiza Silveira Mello
Maria Luiza Silveira Mello